Mostrar el registro sencillo del ítem
dc.contributor.author
Molina, María Alejandra
dc.contributor.author
Wedepohl, Stefanie
dc.contributor.author
Miceli, Enrico
dc.contributor.author
Calderon, Marcelo
dc.date.available
2020-02-27T17:29:35Z
dc.date.issued
2016-11-23
dc.identifier.citation
Molina, María Alejandra; Wedepohl, Stefanie; Miceli, Enrico; Calderon, Marcelo; Overcoming drug resistance with on-demand charged thermoresponsive dendritic nanogels; Future Medicine; Nanomedicine; 12; 2; 23-11-2016; 117-129
dc.identifier.issn
1743-5889
dc.identifier.uri
http://hdl.handle.net/11336/98517
dc.description.abstract
To develop nanogels (NG) able to modulate the encapsulation and release of drugs, in order to circumvent drug resistance mechanisms in cancer cells. Materials & methods: Poly-N-isopropylacrylamide-dendritic polyglycerol NG were semi-interpenetrated with 2-acrylamido-2-methylpropane sulfonic acid or (2- dimethylamino) ethyl methacrylate. Physico-chemical properties of the NGs as well as doxorubicin (DOXO) loading and release were characterized. Drug delivery performance was investigated in vitro and in vivo in a multidrug-resistant tumor model. Both the DOXO loaded semi-interpenetrating polymer network NGs were more efficient in multidrug resistant cancer cell proliferation inhibition studies. In vivo, the DOXO loaded NG semi-interpenetrated with 2-acrylamido-2-methylpropane sulfonic acid was able to overcome drug resistance and reduce the tumor volume to about 25%. The innovative semi-interpenetrating polymer network NGs appear to be promising drug carriers for drug resistant cancer therapy.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Future Medicine
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
DOXORUBICIN CARRIER
dc.subject
DRUG RESISTANCE
dc.subject
SEMI-INTERPENETRATED PNIPAM
dc.subject.classification
Nano-materiales
dc.subject.classification
Nanotecnología
dc.subject.classification
INGENIERÍAS Y TECNOLOGÍAS
dc.title
Overcoming drug resistance with on-demand charged thermoresponsive dendritic nanogels
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2020-02-12T17:46:56Z
dc.identifier.eissn
1748-6963
dc.journal.volume
12
dc.journal.number
2
dc.journal.pagination
117-129
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Molina, María Alejandra. Universidad Nacional de Río Cuarto. Facultad de Ciencias Exactas Fisicoquímicas y Naturales. Departamento de Química; Argentina. Freie Universität Berlin; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
dc.description.fil
Fil: Wedepohl, Stefanie. Freie Universität Berlin; Alemania
dc.description.fil
Fil: Miceli, Enrico. Freie Universität Berlin; Alemania. Helmholtz Virtual Institute On Multifunctional Biomaterials For Medicine; Alemania
dc.description.fil
Fil: Calderon, Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Río Cuarto. Facultad de Ciencias Exactas Fisicoquímicas y Naturales. Departamento de Química; Argentina. Helmholtz Virtual Institute On Multifunctional Biomaterials For Medicine; Alemania. Freie Universität Berlin; Alemania
dc.journal.title
Nanomedicine
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2217/nnm-2016-0308
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.futuremedicine.com/doi/abs/10.2217/nnm-2016-0308
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/27879151
Archivos asociados